Corticotropin-releasing hormone in depression and post-traumatic stress disorder

Peptides

Volumn 22, Issue 5, 2001, Pages 845-851

  Kasckow, J W ^a,b   Baker, D ^a,b   Geracioti Jr , T D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

ACTH; Atypical depression; Cerebrospinal fluid; Corticotropin releasing hormone; Cortisol; Depression; Hypothalamic pituitary adrenal axis; Melancholic depression; Post traumatic stress disorder

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ANXIETY NEUROSIS; AROUSAL; ARTICLE; CEREBROSPINAL FLUID; DEPRESSION; FEEDING; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MELANCHOLIA; MOTOR PERFORMANCE; NEUROENDOCRINOLOGY; NONHUMAN; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REPRODUCTION;

ADRENOCORTICOTROPIC HORMONE; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0035042994     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00399-0     Document Type: Article

References (83)

1. Elevated CSF CRH in suicide victims
2. Serial Corticotropin-Releasing Hormone Levels and Adrenocortical Activity in Combat Veterans with Posttraumatic Stress Disorder
3. Cerebrospinal fluid corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
4. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
5. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications
6. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications
7. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
8. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - A preliminary report
9. A Specific Laboratory Test for the Diagnosis of Melancholia
10. Limbic system-adrenal cortex regulation in depression and schizophrenia
11. Cortisol measures in primary major depressive disorder with hypersomnia or appetite increase
12. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis
13. The role of the amygdala in conditioned fear
14. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression
15. Repeated stress enhances vasopressin synthesis in corticotropin-releasing factor neurons in the paraventricular nucleus
16. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
17. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome
18. CSF corticotropin-releasing factor-like immunoreactivity in chronic pain patients with and without major depression
19. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression
20. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans
21. Psychiatric Implications of Basic and Clinical Studies with Corticotropin-Releasing Factor
22. Clinical and biochemical maifestations of depression. Relation to the neurobiology of stress
23. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications
24. Autonomic neuropeptide connections of the amygdala
25. The organization and possible function of amygdaloid corticotropin-releasing factor pathways
26. Mood disorders
27. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder
28. Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients
29. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action
30. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment
31. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
32. Human corticotropin-releasing hormone (CRH) in depression
33. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders
34. ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression
35. Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients - Physiologic abd clinical construct validity of the DST
36. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression
37. Corticotropin-releasing factor binding sites in cortex of depressed suicides
38. Behavioral and plasma cortisol responses to sodium lactate infusion in posttraumatic stress disorder
39. Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus
40. Peptidergic alterations in stress
41. Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: Preliminary findings
42. Stress-responsive neurohormonal systems and the symptom complex of affective illness
43. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: Potential clinical applications
44. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression
45. Abuse-related posttraumatic stress disorder: Evidence for chronic neuroendocrine activation in women
46. Intra-amygdala injections of corticotropin-releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats
47. Psychopharmacologic validation of atypical depression
48. Augmented pituitary corticotropin-response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone
49. Urinary free cortisol levels in posttraumatic stress disorder patients
50. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders
51. Corticosteroid receptor function is decreased in depressed patients
52. CSF somatostatin in Alzheimer's disease and major depression: Relationship to hypothalamic-pituitary-adrenal axis and clinical measures
53. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy
54. Reduced corticotropin-releasing factor binding sites in the frontal cortex of suicide victims
55. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
56. Physiology and pharmacology of corticotropin-releasing factor
57. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
58. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder
59. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls
60. The dexamethasone suppression test in violent suicide attempters with major depression
61. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression
62. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
63. Corticosteroids in depressive illness. II. A longitudinal psychoendocrine study
64. Neuroendocrine studies of depressive illness
65. Behavioral, endocrine, and hypothalamic responses to involuntary overfeeding
66. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder
67. Behavioral activation of CRF: Evidence for the involvement of the ventral forebrain
68. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin
69. Corticotropin-releasing factor (CRF) family of ligands and their receptors
70. Cortisol response to a combined dexamethasone-hCRH challenge in patients with depression
71. Effect of age upon the cortisol response to human CRH in depressed patients pretreated with dexamethasone
72. Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pre-treatment
73. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone
74. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder
75. Psychoneuroendocrine assessment of posttraumatic stress disorder: Current progress and new directions
76. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder
77. Low urinary cortisol excretion in holocaust survivors with posttraumatic stress disorder
78. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder
79. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder
80. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder
81. Low urinary cortisol excretion in patients with posttraumatic stress disorder
82. Cortisol regulation in posttraumatic stress disorder and major depression: A chronobiological analysis
83. Evidence against changes in corticotroph CRF receptors in depressed patients